Archives
What High-Yield Rabbit Pharming Evidence Shows
2026-11-10
A targeted rabbit line produced 15–20 g/L of a recombinant reporter protein in milk, but the result is best interpreted as a proof of concept for locus-directed expression rather than as a general production benchmark.
Why CSN2 Targeting Raises Rabbit Milk Output
2026-11-10
A mechanistic reading of evidence linking endogenous CSN2-locus targeting with high recombinant-protein concentrations in rabbit milk, including what the study establishes, what remains confounded, and how broadly the result can be applied.
What a CSN2 Rabbit Pharming Study Shows
2026-11-09
A 2025 study examined whether targeted placement of a reporter gene under the rabbit CSN2 milk-protein regulatory region could raise recombinant protein output. Its results are striking but preliminary: high milk concentrations were reported in two homozygous animals, while broader questions about cargo-specific performance, product quality, animal physiology and reproducibility remain open.
Why CSN2 Targeting Matters in Rabbit Pharming
2026-11-09
A literature-focused analysis of a 2025 study showing that targeted placement of a reporter transgene under the rabbit CSN2 regulatory context was associated with markedly higher milk concentrations than conventional pharming benchmarks, while emphasizing the study’s small animal number, reporter-based readout, and limits on therapeutic generalization.
A Targeted Route to Higher Rabbit Pharming Yields
2026-11-08
Song and colleagues tested whether placing a reporter gene under the endogenous rabbit CSN2 milk-protein promoter could overcome the variability and low output associated with conventional transgenic pharming. The study reported 15–20 g/L tdTomato in milk from two homozygous rabbits, while also highlighting important limits: the result concerns a reporter protein, a small animal group, and cross-study comparisons rather than a direct therapeutic-protein manufacturing trial.
Why the CSN2 Locus Raises Rabbit Pharming Yield
2026-11-07
A targeted insertion strategy placed a reporter gene under the endogenous rabbit CSN2 regulatory context, producing substantially higher milk concentrations than most historically reported rabbit pharming lines. The result supports a strong locus-dependent effect, but remains a proof of concept because the main quantitative result came from a reporter protein and a small number of homozygous animals.
When Context Changes a Pharming Result
2026-11-06
A high concentration in rabbit milk can demonstrate successful expression without, by itself, proving therapeutic-product performance or industrial productivity. The meaning of the result depends on the genetic locus, reporter, comparator, animal cohort and measurement used.
Reciprocal Glial Signaling in Spinal Cord Repair
2026-11-06
A mouse study supports a reciprocal repair model in which astrocyte-derived CSF1 supports lesion-associated microglia, while microglial IFN-β signaling supports astrocyte survival and coordinated wound repair. Genetic perturbations and rescue experiments indicate that the two pathways cooperate but are not interchangeable.
What a High-Yield Rabbit Pharming Study Shows
2026-11-05
A recent rabbit study links targeted integration at the endogenous CSN2 milk-protein locus with markedly higher reporter-protein concentrations than those commonly reported for conventional transgenic lines. The result is biologically plausible and quantitatively notable, but it remains a proof-of-concept rather than a definitive head-to-head demonstration. The small number of high-producing animals, use of tdTomato rather than a therapeutic protein, historical rather than matched comparators, and unresolved questions about product quality and long-term consistency all limit how broadly the finding can be generalized.
Why CSN2 Matters for Rabbit Pharming
2026-11-05
A literature-focused analysis of how targeted expression from the endogenous CSN2 locus was associated with markedly higher recombinant protein levels in rabbit milk, while distinguishing reporter expression from therapeutic-product validation.
CSN2 Targeting and Rabbit Pharming Yield
2026-11-04
A 2025 study links targeted insertion at the endogenous CSN2 milk-protein locus with unusually high tdTomato concentrations in rabbit milk. The findings support a mechanistic role for promoter context and controlled genomic placement, but the small reporter-focused dataset does not yet establish equivalent performance for therapeutic proteins or prove that promoter choice alone caused the increase.
Why CSN2 Targeting Raised Rabbit Pharming Yields
2026-11-04
A literature-focused analysis of how targeted insertion at the rabbit CSN2 locus was linked to high reporter-protein concentrations in milk, what the study actually demonstrated, and which uncertainties limit interpretation beyond this reporter model.
Targeted Rabbit Pharming: What the Evidence Shows
2026-11-03
A 2025 study linked targeted insertion at the rabbit CSN2 locus with substantially higher reporter-protein levels in milk, but the result remains an early, small-scale demonstration rather than proof of general therapeutic-protein manufacturing performance.
The CSN2 Locus and High-Yield Rabbit Pharming
2026-11-03
A targeted rabbit line links an endogenous milk-protein regulatory locus to markedly higher reporter concentration in milk, but the evidence supports feasibility rather than a universal production rule. The key mechanistic uncertainty is how much of the result comes from promoter context, targeted integration, allele dosage, or properties specific to the reporter protein.
Why the CSN2 Locus Matters in Rabbit Pharming
2026-11-02
A targeted rabbit line illustrates how endogenous milk-protein regulation can influence recombinant-protein output. The reported result is mechanistically consistent with promoter activity, chromatin context, and controlled transgene dosage, but the evidence remains narrower than a general production platform: it centers on a tdTomato reporter, two homozygous females, and milk concentration rather than therapeutic-protein function or total yield.